Bernard Sablonnière

Targeting Chelatable Iron as a Therapeutic Modality in Parkinson's Disease

David Devos, Caroline Moreau, Jean Christophe Devedjian et al. · Antioxidants and Redox Signaling · 2013 · 613 citations · Full text

Medicine, Neurology, Pharmacology +17

Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study

Davina J. Hensman Moss, Antonio F. Pardiñas, Douglas R. Langbehn et al. · The Lancet Neurology · 2017 · 332 citations · Full text

Life Sciences, Genetics, Molecular Genetics +14

Symptomatic hyperlactataemia: an emerging complication of antiretroviral therapy

Y Gérard, Laurence Maulin, Yazdan Yazdanpanah et al. · AIDS · 2000 · 193 citations

Medicine, Infectious Diseases, Pharmacology +13

Methylphenidate for gait hypokinesia and freezing in patients with Parkinson's disease undergoing subthalamic stimulation: a multicentre, parallel, randomised, placebo-controlled trial

Caroline Moreau, Arnaud Delval, Luc Defebvre et al. · The Lancet Neurology · 2012 · 184 citations

Medicine, Neurology, Neuroscience +16

Cerebrospinal fluid amyloid-β 42/40 ratio in clinical setting of memory centers: a multicentric study

Julien Dumurgier, Susanna Schraen, Audrey Gabelle et al. · Alzheimer s Research & Therapy · 2015 · 144 citations · Full text

Medicine, Neurology, Neuroscience +17